A quarter of a century after the explosion in laparoscopic instrumentation, the main protagonists, device giant Covidien and that other device giant Ethicon Endo-Surgery (J&J) are still squabbling about intellectual property. A new injunction prevents Ethicon from manufacturing, marketing and selling the Harmonic ACE®+7.
Connecticut District Court has granted a preliminary injunction against Ethicon Endo-Surgery, Inc., resulting from a lawsuit filed by Covidien in June 2014 that alleges Ethicon’s latest ultrasonic surgical product, the Harmonic ACE®+7, infringes three Covidien patents.
The June 2014 lawsuit contends that U.S. Patents 6,063,050; 6,468,286; and 6,682,544 are infringed by Ethicon’s Harmonic ACE®+7 Shears. Ethicon’s Harmonic® devices were found to infringe the same patents in a prior suit in the same court that resulted in a damages award against Ethicon of more than $175 million, a finding that is currently under appeal.
“Covidien operates within a highly competitive global health care environment. We are pleased that the court has recognized the value of our intellectual property. As demonstrated by our actions, we will vigorously protect our innovative products, solutions and intellectual property,” said Chris Barry, president, Advanced Surgical, Covidien.
Source: Covidien, plc., Business Wire